What can I Expect as an Enrolled Patient?

Patient enrollment is complete for the LIFE-BTK PK sub-study. A special thanks to the investigators, research coordinators, and enrolled patients for making this sub-study possible.

What to Expect if You Participate in the LIFE-BTK PK SUB-STUDY

This sub-study will evaluate how everolimus is processed in our body during and after Esprit™ BTK implantation in patients with CLI.

Study participants will have their blood drawn starting on the day of the Esprit™ BTK implantation procedure and for up to 60 days. You will have 16 study visits over a 5-year period, some matching the same time points for your blood draws.

After implantation of Esprit™ BTK, study participants will have their blood drawn on specific days for up to 60 days. After 60 days, when all blood draws are completed, you will have 7 study visits remaining over a 5-year period. Duplex ultrasound testing, to assess your leg arteries, will be conducted at 30 days, 180 days, and 1 year.

Life-BTK Patient Blood Draw

For full site functionality you must enable functional and advertising cookies.

This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We may also share information about your use of our site with our social media, advertising and analytics partners. For more information about how Abbott uses cookies please see our Cookie Policy and Privacy Policy.

In order to accept functional and advertising cookies, please click "Enable Cookies" and then click "Accept Sale/Sharing and Targeted Advertising" to view the full site.